Answer to Question 1
Ans: A
Feedback:
When levodopa and adrenergic blockers are administered together, the effect of the levodopa is decreased. Therefore, the client's Parkinson's disease may not be controlled as effectively as before. The effect of the adrenergic blocker is not increased, nor is the risk for levodopa toxicity. The client is not experiencing psychotic behavior.
Answer to Question 2
Ans: A
Feedback:
The nurse should ask about the relief of symptoms and record the responses on the client's chart. Determining the signs of infection in the client is part of the nurse's preadministration assessment, not the ongoing assessment. The nurse need not monitor the client for a sudden decrease in urine output and a sudden increase in intraocular pressure for a client receiving propranolol therapy for angina.